Drug product
Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
D-0583-2016
Product summary
- Event
- Event 72629
- Status
- Terminated
- Classification
- Class II
- Quantity
- N/A
- Official record key
drug-enforcement:D-0583-2016
Official wording
Reason: Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Code information: Lot #: 1837@2, exp. 1/17/2016; 1646@6, exp. 12/20/2015
Distribution pattern: Nationwide and Puerto Rico
Derived failure modes
-
Foreign material or chemical contamination
particulate matter